Multispecialty Approach to a Very Large Congenital Head and Neck Cystic Lymphatic Malformation in an Infant Born by SARS-CoV-2 Positive Mother—A Case Report
Greta Sibrecht,
Katarzyna Wróblewska-Seniuk,
Jakub Kornacki,
Daniel Boroń,
Jarosław Szydłowski,
Anna Kłosowska,
Ewa Bień,
Ewa Wender-Ożegowska,
Tomasz Szczapa
Affiliations
Greta Sibrecht
II Department of Neonatology, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Katarzyna Wróblewska-Seniuk
II Department of Neonatology, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Jakub Kornacki
Department of Reproduction, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Daniel Boroń
Department of Reproduction, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Jarosław Szydłowski
Department of Pediatric Otorhinolaryngology, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Anna Kłosowska
Department of Pediatrics, Hematology and Oncology, Medical University, 80-210 Gdansk, Poland
Ewa Bień
Department of Pediatrics, Hematology and Oncology, Medical University, 80-210 Gdansk, Poland
Ewa Wender-Ożegowska
Department of Reproduction, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Tomasz Szczapa
II Department of Neonatology, Poznan University of Medical Sciences, 61-701 Poznan, Poland
Masses of the head and neck are often diagnosed prenatally and require special care due to the risk of airway obstruction. The EXIT procedure is a preferable mode of delivery. A congenital cystic lymphatic malformation is one of the most common lesions of the cervical region described in neonates. The treatment consists of different strategies and involves the cooperation of multiple specialists. Up to now, no guidelines or protocols are available. We report a case of a congenital cystic lymphatic malformation of the head and neck delivered during the EXIT procedure by a mother who was SARS-CoV-2 positive. We analyzed clinical characteristics, radiologic features, and treatment with injections of sclerotic agents and orally administrated sirolimus. Sirolimus seems a valuable and safe therapeutic option for treating lymphatic malformations, especially with adjunct therapies.
